Results 61 to 70 of about 1,882,441 (191)
Mendelian randomization (MR) studies were conducted using the inverse‐variance weighted (IVW) method, MR‐Egger and weighted median on juvenile myoclonic epilepsy (JME), and systemic lupus erythematosus (SLE) data from the Integrative Epidemiology Unit (IEU) Open genome‐wide association study (GWAS) database and the International League Against Epilepsy
Sirui Chen +10 more
wiley +1 more source
Multi‐omics–driven precision medicine
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li +20 more
wiley +1 more source
Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature [PDF]
Cutaneous manifestations occur frequently in systemic lupus erythematosus (SLE) and are pathognomonic in subacute-cutaneous lupus erythematosus (SCLE) and chronic cutaneous lupus erythematosus (CCLE).
Morris, SD +3 more
core
Percentages of lymphocyte subsets in the juvenile-onset systemic lupus erythematosus patients.
Percentages of lymphocyte subsets in the juvenile-onset systemic lupus erythematosus patients.
Butsabong Lerkvaleekul (12055191) +5 more
core +1 more source
Nail Disorders in Systemic Conditions
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley +1 more source
Childhood-onset bullous systemic lupus erythematosus
Bullous systemic lupus erythematosus has rarely been described in pediatric lupus population and the real prevalence of childhood-onset bullous systemic lupus erythematosus has not been reported.
Campos, L. M. A. +5 more
core +1 more source
Demographic, clinical, and laboratory parameters of the juvenile-onset systemic lupus erythematosus patients.
Butsabong Lerkvaleekul (12055191) +5 more
core +1 more source
Predictors of remission on therapy in the juvenile-onset systemic lupus erythematosus patients.
Predictors of remission on therapy in the juvenile-onset systemic lupus erythematosus patients.
Butsabong Lerkvaleekul (12055191) +5 more
core +1 more source
Sera from patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease (ILD) exhibit significantly higher type I interferon (IFN‐I) bioactivity and interferon‐stimulated gene‐inducing activity compared to anti‐ARS‐positive ILD and healthy controls.
Shohei Nakamura +3 more
wiley +1 more source
Systemic lupus erythematosus with juvenile onset: current status of the problem (literature review)
Patients with juvenile-onset systemic lupus erythematosus (jSLE) account for up to 25% of all SLE patients. The main difference between jSLE and SLE in adults is the greater role of genetic factors in the pathogenesis, higher activity, earlier ...
M. I. Kaleda, I. P. Nikishina
doaj +1 more source

